EAU guidelines on benign prostatic hyperplasia (BPH)

被引:172
作者
de la Rosette, JJMCH
Alivizatos, G
Madersbacher, S
Perachino, M
Thomas, D
Desgrandchamps, F
De Wildt, M
机构
[1] Univ Nijmegen, Med Ctr Radboud, Ctr Minimal Invas Urol, NL-6500 HB Nijmegen, Netherlands
[2] Athens Med Sch, Athens, Greece
[3] Univ Hosp Vienna, A-1090 Vienna, Austria
[4] Osped Santa Corona, Pietra Ligure, Italy
[5] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[6] Hop St Louis, F-75475 Paris, France
关键词
EAU guidelines; benign prostatic hyperplasia; diagnosis; treatment; follow-up;
D O I
10.1159/000049784
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective:To establish guidelines for the diagnosis, treatment, and follow-up of BPH. Methods:A search of published work was conducted using Medline. In combination with expert opinions, recommendations were made on the usefulness of tests for assessment and follow-up: mandatory, recommended, or optional. In addition, indications and outcomes for the different therapeutic options, were: reviewed. Results:A digital rectal examination is mandatory in the assessment for the diagnosis of BPH:. Recommended tests are the International Prostate Symptom Score, creatinine measurement (or renal, ultrasound), uroflowmetry, and postvoid residual urine volume. All other tests are optional. The aim of treatment is to improve patients' quality of life, and it depends on the severity of the symptoms of BPH. The watchful waiting policy is recommended for patients with mild symptoms, medical treatment for patients with mild-moderate symptoms, and surgery for patients who failed medication or conservative management and who have moderate-severe symptoms, and/or complications of BPH which require surgery. Regarding non-surgical treatments, transurethral microwave thermotherapy is the most attractive option. These treatments should be reserved for patients who prefer to avoid surgery or who no longer respond favourably to medication. Finally, recommendations for follow-up tests and a recommended follow-up time schedule. after BPH treatment are provided. Conclusions: Recommendations for assessment, possible therapeutic options, and follow-up. of patients with BPH are made.. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:256 / 263
页数:8
相关论文
共 45 条
[1]   Transrectal ultrasound of the prostate: Innovations and future applications [J].
Aarnink, RG ;
Beerlage, HP ;
De la Rosette, JJMCH ;
Debruyne, FMJ ;
Wijkstra, H .
JOURNAL OF UROLOGY, 1998, 159 (05) :1568-1579
[2]   Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique [J].
Aarnink, RG ;
DelaRosette, JJMCH ;
Debruyne, FMJ ;
Wijkstra, H .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :219-223
[3]  
Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47
[4]   CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY [J].
ANDERSEN, JT ;
EKMAN, P ;
WOLF, H ;
BEISLAND, HO ;
JOHANSSON, JE ;
KONTTURI, M ;
LEHTONEN, T ;
TVETER, K ;
BODKER, A ;
VEDEL, O ;
NORDLING, J ;
POULSEN, AL ;
SCHOU, J ;
HVIDT, V ;
HANSEN, JB ;
MEYHOFF, HH ;
ELDRUP, J ;
HARTWELL, D ;
COLSTRUP, H ;
LYNGDORF, P ;
NIELSEN, AH ;
LARSEN, E ;
WALTER, S ;
LARSEN, EH ;
THYBO, E ;
MOMMSEN, S ;
BROK, KE ;
PALM, L ;
GENSTER, H ;
ANDERSEN, M ;
KAUPPINEN, P ;
RAUVALA, M ;
HAKKINEN, J ;
TAMMELA, T ;
TAINIO, H ;
HYNNINEN, O ;
TIITINEN, J ;
LEHTORANTA, K ;
ALAOPAS, M ;
PERTTILA, I ;
PETAS, A ;
RINTALA, E ;
SALMINEN, R ;
JUUSELA, H ;
HANSSON, E ;
VONWENDT, R ;
TUHKANEN, K ;
TALJA, M ;
NURMI, M ;
PUNTALA, P .
UROLOGY, 1995, 46 (05) :631-637
[5]   Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: Results of a randomized, double-blind, placebo-controlled clinical trial [J].
Andriole, GL ;
Guess, HA ;
Epstein, JI ;
Wise, H ;
Kadmon, D ;
Crawford, ED ;
Hudson, P ;
Jackson, CL ;
Romas, NA ;
Patterson, L ;
Cook, TJ ;
Waldstreicher, J .
UROLOGY, 1998, 52 (02) :195-201
[6]   Immediate and postoperative complications of transurethral prostatectomy in the 1990s [J].
Borboroglu, PG ;
Kane, CJ ;
Ward, JF ;
Roberts, JL ;
Sands, JP .
JOURNAL OF UROLOGY, 1999, 162 (04) :1307-1310
[7]   Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials [J].
Boyle, P ;
Gould, AL ;
Roehrborn, CG .
UROLOGY, 1996, 48 (03) :398-405
[8]   Introduction and concluding remarks [J].
Chapple, CR .
EUROPEAN UROLOGY, 1999, 36 :1-6
[9]  
CHAPPLE CR, 1997, P 4 INT CONS BEN PRO, P610
[10]   THE PREVALENCE OF PROSTATISM - A POPULATION-BASED SURVEY OF URINARY SYMPTOMS [J].
CHUTE, CG ;
PANSER, LA ;
GIRMAN, CJ ;
OESTERLING, JE ;
GUESS, HA ;
JACOBSEN, SJ ;
LIEBER, MM .
JOURNAL OF UROLOGY, 1993, 150 (01) :85-89